A selective inhibitor reveals PI3Kγ dependence of TH17 cell differentiation
Nature Chemical Biology2012Vol. 8(6), pp. 576–582
Citations Over TimeTop 10% of 2012 papers
Giovanna Bergamini, Kathryn M. Bell, Satoko Shimamura, Thilo Werner, Andrew D. Cansfield, K. H. Müller, Jessica Perrin, Christina Rau, Katie Ellard, Carsten Hopf, Carola Doce, Daniel Leggate, Raffaella Mangano, Toby Mathieson, Alison O’Mahony, Ivan Plavec, Faı̈za Rharbaoui, Friedrich Reinhard, Mikhail M. Savitski, Nigel G. Ramsden, Emilio Hirsch, Gerard Drewes, Oliver Rausch, Marcus Bantscheff, Gitte Neubauer
Related Papers
- → Targeting PI3K/AKT/mTOR network for treatment of leukemia(2015)244 cited
- → Beyond PI3Ks: targeting phosphoinositide kinases in disease(2022)133 cited
- → LY294002 and Rapamycin promote coxsackievirus-induced cytopathic effect and apoptosis via inhibition of PI3K/AKT/mTOR signaling pathway(2013)39 cited
- → PI3K/Akt/mTOR Pathway: A Growth and Proliferation Pathway(2009)18 cited
- → Advancement of PI3K-mTOR signaling pathway(2008)